Pancreatitis clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, not yet accepting patients
Determine if IV ketorolac is an effective agent in the prevention of post-ERCP pancreatitis. Determine if IV ketorolac provides improved post-procedure analgesia. Determine if systemic mediators of inflammation are reduced in patients receiving IV ketorolac following ERCP.
San Francisco, California and other locations